Hereditary Cancer Genetics Evaluation Program | Loyola Medicine

Hereditary Cancer Genetics Evaluation Program

Assess Your Family History and Genetic Risk of Cancer

Loyola Medicine is proud to offer you a comprehensive cancer genetics evaluation program. Developed to help individuals and families with a hereditary susceptibility to cancers understand their risk, the program offers consultation to all patients who are concerned that they are at an increased risk for cancer.

While our program is open to all cancer types, the most common are breast, ovarian, colon and uterine. Genetic counselors, along with a team of oncology specialists, provide individualized family history analysis, genetic risk evaluation and, when appropriate, strategies to reduce risk.
This program is especially useful if you or a relative:

  • Had cancer at an early age
  • Had more than one cancer or bilateral cancer
  • Had a rare or unusual cancer such as male breast cancer or adrenal gland cancer
  • Have several relatives who have had cancer
  • Have a known gene mutation or syndrome that causes susceptibility to cancer (i.e. BRCA1, BRCA2, Lynch syndrome, Li-Fraumeni syndrome)

Why Choose Loyola for Genetics Risk Evaluation?

If your comprehensive evaluation indicates an increased risk for cancer, Loyola works with you to establish an individualized surveillance program for early detection. In addition, our team of professionals may recommend cancer prevention strategies such as risk-reducing medications or surgeries.

When you visit Loyola, a multidisciplinary team of professionals will conduct a genetics risk evaluation for you. This evaluation may include the following:

  • Comprehensive review of family and medical histories
  • Counseling to promote informed choices based on your risk
  • Education about inheritance, testing, management and resources
  • Genetic testing, if applicable

When indicated, genetic testing is typically covered by insurance, including Medicare and Medicaid.